These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9377723

  • 41. Vasoactive factors and tubulointerstitial injury.
    Wolf G.
    Kidney Blood Press Res; 1999; 22(1-2):62-70. PubMed ID: 10352409
    [Abstract] [Full Text] [Related]

  • 42. Endothelins: vasoactive modulators of renal function in health and disease.
    Naicker S, Bhoola KD.
    Pharmacol Ther; 2001 Apr; 90(1):61-88. PubMed ID: 11448726
    [Abstract] [Full Text] [Related]

  • 43. Endothelins in the normal and diseased kidney.
    Kohan DE.
    Am J Kidney Dis; 1997 Jan; 29(1):2-26. PubMed ID: 9002526
    [Abstract] [Full Text] [Related]

  • 44. Endothelin in kidney disease.
    Nassar GM, Badr KF.
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):86-91. PubMed ID: 7850416
    [Abstract] [Full Text] [Related]

  • 45. An emerging role for endothelin in renal disease.
    Shultz PJ.
    J Lab Clin Med; 1992 May; 119(5):448-9. PubMed ID: 1583397
    [No Abstract] [Full Text] [Related]

  • 46. Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.
    Gohar EY, Giachini FR, Pollock DM, Tostes RC.
    Life Sci; 2016 Aug 15; 159():20-29. PubMed ID: 26939577
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Targets for endothelin in the diseased kidney: clues for therapeutic intervention.
    Rohmeiss P, Birck R, Braun C, Kirchengast M, van der Woude FJ.
    Exp Nephrol; 1999 Aug 15; 7(1):1-10. PubMed ID: 9892807
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The adverse effects of cholesterol in progressive glomerular injury.
    Diamond JR.
    Md Med J; 1994 May 15; 43(5):451-5. PubMed ID: 8052098
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Renal actions of endothelin: linking cellular signaling pathways to kidney disease.
    Marsen TA, Schramek H, Dunn MJ.
    Kidney Int; 1994 Feb 15; 45(2):336-44. PubMed ID: 8164417
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Perspectives in endothelin research: tubulointerstitial actions of endothelins in the kidney: roles in health and disease.
    Ong AC.
    Nephrol Dial Transplant; 1996 Feb 15; 11(2):251-7. PubMed ID: 8671775
    [No Abstract] [Full Text] [Related]

  • 57. [Role of endothelin in the pathogenesis of renal and cardiovascular diseases].
    Wiecek A, Szurkowski M.
    Pol Arch Med Wewn; 1992 Nov 15; 88(5):330-5. PubMed ID: 1300553
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Clinico-morphological data on renal involvement in children with lupus].
    Kartashova VI, Lysenko AI.
    Vopr Okhr Materin Det; 1965 Dec 15; 10(12):16-23. PubMed ID: 5873524
    [No Abstract] [Full Text] [Related]

  • 60. Endothelin, nephropathy, and blood pressure.
    Luft FC.
    J Mol Med (Berl); 2002 Feb 15; 80(2):69-70. PubMed ID: 11907642
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.